- Detachable
- Pushable
- Balloon Assisted
- Stent-Assisted
- Others
The occlusion systems market size was valued at USD 4.8 billion by 2029 growing at a CAGR of 5.6% during the forecast period 2023 to 2029. Occlusion systems are the closure devices used in embolization procedure which are performed to prevent the blood flow to any part of body, which can effectively shrink a tumor or block aneurysm. Occlusion systems are especially used in the procedure of embolization. These are the closure devices performed for the prevention of the blood flow to body part, which may shrink a tumor effectively. Increase in healthcare expenses in developing economies and approving reimbursement policies in developed countries for diagnosing and treating the cancer are anticipated to foster the global occlusion systems market during the forecast years. In addition, growing demand for the cancer treatment techniques due to the growing population is also projected to boost the market share. A obstruction of blood arteries or hollow organs is referred to as occlusion in medical jargon. Occlusion devices are medical devices that are used to correct a variety of problems in a patient's body. Occlusion devices can be used to treat cardiovascular, neurological, gynaecological, and oncological defects. The occlusion therapy devices have been clinically proven to be successful in removing occlusions from various regions of the body.
Global Occlusion Systems Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.6%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Occlusion Systems Market Dynamics
Global occlusion systems market is expected to gain traction over the forecast period due to increase in the cancer prevalence worldwide. Furthermore, growth in demand for the techniques to treat cancer coupled with growing awareness is expected to boost the market share over the forecast period. According to WHO, GLOBOCAN 2012 data, about 12.1 million cancer cases in 2012. The number is expected to grow up to 24 million by 2035. In addition, favorable reimbursement policies in developed countries in order to diagnosis and treatment of cancer, growing healthcare spending in developing countries projected to boost the global occlusion systems market during the forecast period. However, high cost of the treatment procedure and stringent regulatory policies are expected to hamper the market growth over the forecast period.
North-America got significant share
Occlusion Systems Market Regional Analysis
Geographically global occlusion systems market is divided into five key regions, i.e. North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. North America occlusion systems market is expected to grow at significant rates owing to the factors such as growing prevalence of cancer, technological advancements and favorable reimbursement policies in the region. According to National Cancer Institute, in 2016, about1,685,210 new cancer cases diagnosed and 595,690 people will die from the disease in United States alone. Asia Pacific expected to have the lucrative growth opportunity owing to the factors such as growing healthcare spending, government initiatives on growth of awareness related to cancer. In addition expansion of the multinational companies into emerging Asian countries such as India and China projected to further expand the market share of region. Europe occlusion systems market is expected to have significant growth rate due to presence of key competitors growing prevalence of the diseases such as cancer and peripheral vascular diseases.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The occlusion systems market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Occlusion Systems Market Segmentation
By Type
By Application
- Oncology
- Peripheral Vascular Disease
- Urology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
The Occlusion Systems Market size was valued at USD 4.8 billion by 2029
The Occlusion Systems Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Asia Pacific is the fastest-growing for Occlusion Systems Market
| 1.Executive Summary |
| 2.Global Occlusion Systems Market Introduction |
| 2.1.Global Occlusion Systems Market - Taxonomy |
| 2.2.Global Occlusion Systems Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Occlusion Systems Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Occlusion Systems Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Occlusion Systems Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Detachable |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Pushable |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Balloon Assisted |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Stent-Assisted |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Occlusion Systems Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Oncology |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Peripheral Vascular Disease |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Urology |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Occlusion Systems Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Cancer |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Nephrological diseases |
| 7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Gastrointestinal disorders |
| 7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Occlusion Systems Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Occlusion Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Detachable |
| 9.1.2.Pushable |
| 9.1.3.Balloon Assisted |
| 9.1.4.Stent-Assisted |
| 9.1.5.Others |
| 9.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oncology |
| 9.2.2.Peripheral Vascular Disease |
| 9.2.3.Urology |
| 9.2.4.Others |
| 9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers |
| 9.3.3.Others |
| 9.3.4.Cancer |
| 9.3.5.Nephrological diseases |
| 9.3.6.Gastrointestinal disorders |
| 9.3.7.Others |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Occlusion Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Detachable |
| 10.1.2.Pushable |
| 10.1.3.Balloon Assisted |
| 10.1.4.Stent-Assisted |
| 10.1.5.Others |
| 10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oncology |
| 10.2.2.Peripheral Vascular Disease |
| 10.2.3.Urology |
| 10.2.4.Others |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers |
| 10.3.3.Others |
| 10.3.4.Cancer |
| 10.3.5.Nephrological diseases |
| 10.3.6.Gastrointestinal disorders |
| 10.3.7.Others |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Occlusion Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Detachable |
| 11.1.2.Pushable |
| 11.1.3.Balloon Assisted |
| 11.1.4.Stent-Assisted |
| 11.1.5.Others |
| 11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oncology |
| 11.2.2.Peripheral Vascular Disease |
| 11.2.3.Urology |
| 11.2.4.Others |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers |
| 11.3.3.Others |
| 11.3.4.Cancer |
| 11.3.5.Nephrological diseases |
| 11.3.6.Gastrointestinal disorders |
| 11.3.7.Others |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Occlusion Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Detachable |
| 12.1.2.Pushable |
| 12.1.3.Balloon Assisted |
| 12.1.4.Stent-Assisted |
| 12.1.5.Others |
| 12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oncology |
| 12.2.2.Peripheral Vascular Disease |
| 12.2.3.Urology |
| 12.2.4.Others |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers |
| 12.3.3.Others |
| 12.3.4.Cancer |
| 12.3.5.Nephrological diseases |
| 12.3.6.Gastrointestinal disorders |
| 12.3.7.Others |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Occlusion Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Detachable |
| 13.1.2.Pushable |
| 13.1.3.Balloon Assisted |
| 13.1.4.Stent-Assisted |
| 13.1.5.Others |
| 13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oncology |
| 13.2.2.Peripheral Vascular Disease |
| 13.2.3.Urology |
| 13.2.4.Others |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers |
| 13.3.3.Others |
| 13.3.4.Cancer |
| 13.3.5.Nephrological diseases |
| 13.3.6.Gastrointestinal disorders |
| 13.3.7.Others |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.BVM Medical Ltd. (UK) |
| 14.2.2.ADVANCED LIFESCIENCES LTD. (India) |
| 14.2.3.Abbott Laboratories (St.Jude Medical) (U.S.) |
| 14.2.4.Boston Scientific Corporation (U.S.) |
| 14.2.5.AtriCure (U.S.) |
| 14.2.6.Penumbra, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- BVM Medical Ltd. (UK)
- ADVANCED LIFESCIENCES LTD. (India)
- Abbott Laboratories (St.Jude Medical) (U.S.)
- Boston Scientific Corporation (U.S.)
- AtriCure (U.S.)
- Penumbra, Inc. (U.S.)